BG63327B1 - Липозомен състав, съдържащ селегилин - Google Patents

Липозомен състав, съдържащ селегилин Download PDF

Info

Publication number
BG63327B1
BG63327B1 BG101432A BG10143297A BG63327B1 BG 63327 B1 BG63327 B1 BG 63327B1 BG 101432 A BG101432 A BG 101432A BG 10143297 A BG10143297 A BG 10143297A BG 63327 B1 BG63327 B1 BG 63327B1
Authority
BG
Bulgaria
Prior art keywords
selegiline
salt
composition
composition according
cyclodextrin
Prior art date
Application number
BG101432A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101432A (en
Inventor
Michael Mezei
Jozsef Gaal
Gabor Szekacs
Gyula Szebeni
Tamasne Marmarosi
Kalman Magyar
Jozsef Lengyel
Istvan Szatmari
Agnes Tueri
Original Assignee
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. filed Critical Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Publication of BG101432A publication Critical patent/BG101432A/xx
Publication of BG63327B1 publication Critical patent/BG63327B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Detergent Compositions (AREA)
  • Dental Preparations (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG101432A 1994-10-24 1997-04-22 Липозомен състав, съдържащ селегилин BG63327B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9403073A HU223475B1 (hu) 1994-10-24 1994-10-24 Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására
PCT/HU1995/000052 WO1996012472A1 (en) 1994-10-24 1995-10-20 Liposome composition containing selegilin

Publications (2)

Publication Number Publication Date
BG101432A BG101432A (en) 1997-12-30
BG63327B1 true BG63327B1 (bg) 2001-10-31

Family

ID=10985697

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101432A BG63327B1 (bg) 1994-10-24 1997-04-22 Липозомен състав, съдържащ селегилин

Country Status (30)

Country Link
US (1) US5888536A (de)
EP (1) EP0788349B1 (de)
JP (1) JPH10507749A (de)
KR (1) KR100313149B1 (de)
CN (1) CN1084186C (de)
AT (1) ATE205387T1 (de)
AU (1) AU691348B2 (de)
BG (1) BG63327B1 (de)
BR (1) BR9509517A (de)
CA (1) CA2203513C (de)
CZ (1) CZ287349B6 (de)
DE (1) DE69522701T2 (de)
DK (1) DK0788349T3 (de)
EE (1) EE03418B1 (de)
ES (1) ES2160718T3 (de)
FI (1) FI971743A (de)
HU (1) HU223475B1 (de)
IL (1) IL115754A (de)
NO (1) NO316354B1 (de)
NZ (1) NZ294660A (de)
PL (1) PL183104B1 (de)
PT (1) PT788349E (de)
RO (1) RO116768B1 (de)
RU (1) RU2159106C2 (de)
SK (1) SK281599B6 (de)
TW (1) TW412420B (de)
UA (1) UA44289C2 (de)
WO (1) WO1996012472A1 (de)
YU (1) YU49313B (de)
ZA (1) ZA958999B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1052983A2 (de) * 1998-01-27 2000-11-22 Thomas N. Thomas Verwendung eines mao-a oder mao-b inhibitors zur behandlung der gefässerkrankungen
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
CA2536393A1 (en) * 2003-09-09 2005-06-16 Gilead Sciences, Inc. Use of liposomes which are small unilamellar vesicles for the removal of an entity from a biological sample
US20080233053A1 (en) * 2005-02-07 2008-09-25 Pharmalight Inc. Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
CN1813679A (zh) * 2005-11-30 2006-08-09 上海医药(集团)有限公司 一种紫杉烷脂质体冻干组合物及其制备方法
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
JP5693026B2 (ja) * 2010-03-12 2015-04-01 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
JP5623102B2 (ja) * 2010-03-12 2014-11-12 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
WO2013168167A1 (en) 2012-05-10 2013-11-14 Painreform Ltd. Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
WO2016051424A1 (en) * 2014-09-29 2016-04-07 Council Of Scientific & Industrial Research A formulation useful for delivery of neuro protecting agent
PL3600435T3 (pl) * 2017-03-23 2024-06-17 Lipid Systems Sp. Z.O.O. Wysokowydajne kapsułkowanie związków hydrofilnych w liposomach jednowarstwowych

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588887A5 (de) * 1974-07-19 1977-06-15 Battelle Memorial Institute
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4761288A (en) * 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
FR2713087B1 (fr) * 1993-11-30 1996-02-23 Saurat Jean Hilaire Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.

Also Published As

Publication number Publication date
KR970706797A (ko) 1997-12-01
RU2159106C2 (ru) 2000-11-20
EP0788349B1 (de) 2001-09-12
FI971743A0 (fi) 1997-04-23
PL319875A1 (en) 1997-09-01
HU9403073D0 (en) 1994-12-28
BG101432A (en) 1997-12-30
YU49313B (sh) 2005-06-10
DK0788349T3 (da) 2001-11-26
HUT76053A (en) 1997-06-30
WO1996012472A1 (en) 1996-05-02
RO116768B1 (ro) 2001-06-29
ES2160718T3 (es) 2001-11-16
CN1084186C (zh) 2002-05-08
FI971743A (fi) 1997-04-23
IL115754A0 (en) 1996-01-19
MX9703019A (es) 1997-10-31
SK51797A3 (en) 1997-11-05
CA2203513A1 (en) 1996-05-02
UA44289C2 (uk) 2002-02-15
KR100313149B1 (ko) 2002-02-19
BR9509517A (pt) 1997-12-30
EP0788349A1 (de) 1997-08-13
AU3751895A (en) 1996-05-15
PL183104B1 (pl) 2002-05-31
DE69522701T2 (de) 2002-07-11
IL115754A (en) 1999-07-14
EE03418B1 (et) 2001-06-15
NZ294660A (en) 1998-05-27
PT788349E (pt) 2001-12-28
JPH10507749A (ja) 1998-07-28
NO316354B1 (no) 2004-01-19
TW412420B (en) 2000-11-21
AU691348B2 (en) 1998-05-14
CN1163563A (zh) 1997-10-29
EE9700102A (et) 1997-10-15
ZA958999B (en) 1996-05-15
ATE205387T1 (de) 2001-09-15
NO971870L (no) 1997-06-24
SK281599B6 (sk) 2001-05-10
US5888536A (en) 1999-03-30
DE69522701D1 (de) 2001-10-18
HU223475B1 (hu) 2004-07-28
CZ287349B6 (en) 2000-10-11
CZ114797A3 (en) 1997-10-15
CA2203513C (en) 2001-10-09
YU67195A (sh) 1998-07-10
NO971870D0 (no) 1997-04-23

Similar Documents

Publication Publication Date Title
KR970005171B1 (ko) 아라키돈산 대사물질 관련 리포좀 제조방법 및 그 제제
EP2317993A2 (de) Verfahren zur verabreichung von topischen antimykotischen formulierungen zur behandlung von pilzinfektionen
BG63327B1 (bg) Липозомен състав, съдържащ селегилин
US5364631A (en) Tocopherol-based pharmaceutical systems
EP0382779B1 (de) Auf tocopherol basierte arzneimittelsysteme
US20080193509A1 (en) Liposome Preparation Containing Slightly Water-Soluble Camptothecin
JP4931369B2 (ja) リポソームおよびそれを含む処置用の組成物
JP2003516348A (ja) がん治療のための細胞増殖抑制剤及び電子受容体を含有する医薬製剤
US6013278A (en) Liposomal antineoplaston therapies with markedly improved antineoplastic activity
US20090196914A1 (en) Liposomal l-carnitine
MXPA97003019A (en) Liposoma composition containing selegil
JPH11171772A (ja) 抗腫瘍薬のリポソーム化製剤
WO1991006310A1 (en) Liposomal compositions
CN115843246A (zh) 用于治疗血管瘤的方法和组合物